AmgenvsHarmony Biosciences

AMGN and HRMY stock compared: price, dividend, valuation and results, from SEC filings.

AMGN

Amgen Inc.

$438.82

Value $237B

-1.14%
AMGN's page

HRMY

Harmony Biosciences Holdings, Inc.

$32.98

Value $1.9B

+0.30%
HRMY's page

Amgen (AMGN) has a market value of $237B and Harmony Biosciences (HRMY) $1.9B. Over the last year, with dividends, AMGN moved +33.5% and HRMY -2.6%. The P/E is 25.2 for AMGN and 10.7 for HRMY. Dividend yield: AMGN 2.27%, HRMY none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    AMGN$237B

    HRMY$1.9B

    AMGN is 124 times HRMY

  • Revenue, 12 months

    AMGN$38.9B

    HRMY$989M

    AMGN is 39 times HRMY

  • Net income, 12 months

    AMGN$9.4B

    HRMY$179M

    AMGN is 53 times HRMY

  • Operating margin

    AMGN32.4%

    HRMY22.2%

    10.2 points apart

  • ROIC

    AMGN16.2%

    HRMY15.3%

    0.9 points apart

  • P/E

    AMGN25.2

    HRMY10.7

    AMGN is 2.4 times HRMY

  • Dividend yield

    AMGN2.3%

    HRMY0.0%

    2.3 points apart

  • 5-year return

    AMGN+149.9%

    HRMY-17.5%

    167.4 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

AMGN+149.9%

HRMY-17.5%

10020020222023202420252026
Returns by period
PeriodAMGNWith dividendsHRMYWith dividends
1 year since November 17, 2025+33.5%Price +29.9%-2.6%Price -2.6%
3 years since November 17, 2023+81.6%+22.0% a yearPrice +67.3%+22.8%+7.1% a yearPrice +22.8%
5 years since November 17, 2021+149.9%+20.1% a yearPrice +115.7%-17.5%-3.8% a yearPrice -17.5%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

AMGNAmgenHRMYHarmony Biosciences

Valuation

AMGNHRMY
Valuation
Price$438.82$32.98
Market value$237B$1.9B
Enterprise value (EV)$277B$1.3B
P/E25.210.7
P/E, 5-year median23.015.2
P/B16.51.8
EV/EBIT22.05.9
Free cash flow yield4.1%16.9%

Results and growth

AMGNHRMY
Results and growth
Revenue, 12 months$38.9B$989M
Net income, 12 months$9.4B$179M
Free cash flow, 12 months$9.6B$323M
Earnings per share, 12 months$17.25$3.03
Revenue growth, year on year10.0%21.5%
Revenue growth a year, past+7.6%over 5 years+40.3%over 5 years
EPS growth a year, past+2.9%over 5 years–

Margins and returns on capital

AMGNHRMY
Margins and returns on capital
Gross margin70.9%74.0%
Operating margin32.4%22.2%
Net margin24.1%18.1%
ROIC16.2%15.3%
ROE87.8%19.1%

Balance sheet

AMGNHRMY
Balance sheet
Cash$13.2B$771M
Total debt$54.0B$155M
Net debt / EBITDA2.3–
Interest cover4.8×17.0×

Dividends and buybacks

AMGNHRMY
Dividends and buybacks
Dividend yield2.3%–
Dividend per share, 12 months$9.94–
Dividend growth a year, past+8.1%over 5 years–
Buyback yield––
Shareholder yield2.3%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: AMGN or HRMY

Didn't find what you were looking for?

Ask us
Which is bigger, Amgen or Harmony Biosciences?

By market value, Amgen ($237B) is about 124.0 times Harmony Biosciences ($1.9B), at today's prices.

How did AMGN and HRMY stock do over the last 5 years?

Since November 17, 2021, AMGN's price moved +115.7% and HRMY's -17.5%. With dividends: AMGN +149.9% (+20.1% a year), HRMY -17.5% (-3.8% a year). Past returns do not predict future ones.

Which pays the higher dividend, AMGN or HRMY?

The dividend yield at today's price is 2.27% for Amgen and none for Harmony Biosciences. Over the last twelve months they paid $9.94 and – per share.

What is the P/E of AMGN and HRMY?

At today's price, the P/E is 25.2 for AMGN and 10.7 for HRMY. The median of the last five years was 23.0 and 15.2, which shows where each stands against its own past.

Which has the higher profit margins, Amgen or Harmony Biosciences?

Over the last twelve months, the net margin was 24.1% for Amgen and 18.1% for Harmony Biosciences, and the operating margin 32.4% and 22.2%. Revenue was $38.9B and $989M.

Which is the better investment, Amgen or Harmony Biosciences?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.